Sema4 is founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease.
Learn more
Our unique analytics platform, Centrellis, allows us to offer advanced tools to help providers better manage data for patient populations, launch new clinical studies, and easily compare patient outcomes across a healthcare system.
Learn more
From pregnancy planning to expanded carrier screening, we deploy robust science and cutting-edge tools to give patients more actionable information all along the family journey through advanced genomic testing.
Learn more
We work with health systems to deliver a personalized cancer therapy program, incorporating the latest advances in genome sequencing and network modeling to identify valuable insights to improve patient care.
Learn more
Sema4’s internationally recognized research is run by world leaders in data science, network modeling, multiscale biotechnology, and genomics. We’ve published more than 1,000 peer-reviewed publications in the last five years and remain committed to making new biological discoveries.
Learn moreSema4 has announced a formal partnership with the State of Connecticut to be a COVID-19 testing provider for Connecticut residents. Sema4 will provide viral and antibody testing, along with an end-to-end digital solution.
